NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Clinical Trials Week


Susan Hasty, Publisher
Table of Contents . . . August 4th, 2008
Non-Subscriber - Summaries Only
Related Areas: Other Issues in Clinical Trials Week | Other Publications

Antibody Engineering - Intravenous Gammaglobulin (IVIG) plus Rituximab Improves Chances for Successful Transplantation in High Immunologic-Risk Patients

Bayer HealthCare Pharmaceuticals; Onyx Pharmaceuticals, Inc. - The New England Journal of Medicine Publishes Nexavar Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer

Cell Genesys, Inc. - Final Results From Phase 2 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Published in the American Cancer Society's Journal Cancer

Liver Cancer - =?ISO-8859-1?Q?MultiVu_Video_Feed:_The_New_England_Journa? =?ISO-8

Liver Cancer - The New England Journal of Medicine Publishes Nexavar(R) Study Demonstrating Significant Improvement in Overall Survival in Patients With Liver Cancer

Resverlogix Corp. - Resverlogix's Lead Drug Featured in Key Scientific Publication

Acne Vulgaris - Research from J.S. Weiss and colleagues has provided new data on acne vulgaris

Actinic Keratosis - Data on actinic keratosis described by researchers at University of Regensburg

Acute Leukemia - New acute leukemia data have been reported by W. Stock and co-authors

Anesthesia - New findings reported from University of California describe advances in anesthesia

Angiogenesis - Findings from S. Kesari and co-researchers advance knowledge in angiogenesis

Angiogenesis - New angiogenesis findings from University of Texas described

Angiogenesis - Research from Stanford University provides new data about angiogenesis

Brain Cancer - Findings from Duke University, Preston Robert Tisch Brain Tumor Center provide new insights into brain cancer

Breast Cancer - Recent studies by C. Bunnell and co-authors add new data to breast cancer findings

Breast Cancer - Research on breast cancer detailed by J.L. Bayocalero and co-authors

Breast Cancer - Researchers from University of Pittsburgh report details of new studies and findings in the area of breast cancer

Cancer - Research from J.S. Carew and co-researchers in the area of cancer described

Clinical Trial Research - New findings reported from INSERM describe advances in clinical trial research

Ductal Carcinoma in Situ - Researchers from New York University, Medical Department report on findings in ductal carcinoma in situ

Gynecology - Findings in gynecology reported from M.L. Hensley and co-researchers

Hepatitis C Virus - Investigators at University of Alberta release new data on hepatitis C virus

Hepatocellular Cancer - Research conducted at Columbia University has provided new information about hepatocellular cancer

Hepatocellular Cancer - Research on hepatocellular cancer reported by A.L. Cohn et al

Hypertension - New hypertension data have been reported by scientists at Yonsei University

Leiomyosarcoma - New leiomyosarcoma research from M.L. Hensley and colleagues discussed

Liver Cancer - Recent findings from B.H. Park and co-authors highlight research in liver cancer

Lung Cancer - Research on lung cancer described by H. Zhang and colleagues

Metastatic Cancer - Research from Vanderbilt University has provided new information about metastatic cancer

Myelofibrosis - Data on myelofibrosis discussed by researchers at University of Texas

Nasopharyngeal Carcinoma - Data from Y.H. Li and colleagues advance knowledge in nasopharyngeal carcinoma

Non-Small Cell Lung Cancer - New findings from F. Oshita and co-authors in the area of non-small cell lung cancer published

Non-Small Cell Lung Cancer - Scientists at Chicago Medical Center describe research in non-small cell lung cancer

Ovarian Cancer - Studies from Charite University update current data on ovarian cancer

Pharmacokinetics - Reports outline pharmacokinetics study findings from University of Louvain

Prostate Cancer - Findings from D. Rathkopf et al in prostate cancer reported

Prostate Cancer - New prostate cancer study findings recently were published by researchers at New York University, Medical Department

Schizophrenia - Research from University of Connecticut in the area of schizophrenia published

Thyroid Cancer - Research conducted at University of Texas has updated our knowledge about thyroid cancer

Tuberculosis - Findings from University of Barcelona in tuberculosis reported

Cancer Therapy - National Tumor Institute describes research in cancer therapy

Cancer Therapy - Research from D. Gordon and co-researchers in the area of cancer therapy published

Colon Cancer Therapy - Research conducted at Fudan University, Department of Medical Oncology has provided new information about colon cancer therapy

Drug Development - Researchers from Northwestern University, Robert H. Lurie Comprehensive Cancer Center detail findings in drug development

Leukemia Clinical Trial - Data on leukemia clinical trial published by investigators at Center for Drug Evaluation and Research

Leukemia Clinical Trial - Recent findings from Center for Drug Evaluation and Research highlight research in leukemia clinical trial

Life Sciences - Research on life sciences reported by scientists at Vanderbilt University, Department of Biostatistics

Lung Cancer Therapy - Investigators at Regina Elena Cancer Institute, Division of Medical Oncology release new data on lung cancer therapy

Non-Small Cell Lung Cancer Therapy - New non-small cell lung cancer therapy study findings have been reported by researchers at Roswell Park Cancer Institute, Department of Medicine

Non-Small Cell Lung Cancer Therapy - Research conducted at C. Peschel and co-authors has provided new information about non-small cell lung cancer therapy

Non-Small Cell Lung Cancer Therapy - Research reports on non-small cell lung cancer therapy from A.A. Martoni and colleagues provide new insights

Adverse Drug Reactions - Helicon Study of HT-0712 on Primate Memory Formation Reveals Significant Enhancement

Adverse Drug Reactions - Medivation Announces Publication In the Lancet of Dimebon Pivotal Trial Results In Alzheimers Disease

Alexza Pharmaceuticals, Inc. - Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 Staccato Loxapine

Allos Therapeutics, Inc. - Allos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder

Anxiety Disorders - CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study

BioLineRx Ltd. - BioLineRx's BL-1040 Named One of 10 Most Promising Cardiovascular Projects by Windhover

Biologics - Insmed CEO to Present at Congressional Briefing on Follow-On Biologics

Biopharmaceuticals - Horizon Therapeutics Names Timothy P. Walbert as President and CEO

CombinatoRx, Incorporated - CombinatoRx to Host 2008 R&D Day Event

Duska Therapeutics, Inc. - Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment

Encorium Group, Inc. - Encorium Group Announces $5.1 Million New Business Contract for a Multinational Cardiovascular Trial of an Innovative Anti-thrombotic Agent

Endometriosis - MEDITRINA PHARMACEUTICALS, INC. OPENS INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR PHASE IIB CLINICAL TRIAL WITH MPI-676 IN ENDOMETRIOSIS - Approval of Second IND Marks Major Corporate Milestone and A

Exelixis, Inc. - Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer

Genaera Corporation - Genaera Releases Phase 1 Data and New Preclinical Data on the CNS Function of Trodusquemine MSI-1436 at CBI Obesity Summit

Gilead Sciences, Inc. - Gilead Initiates Phase III Clinical Trial of Elvitegravir, an Investigational Integrase Inhibitor for HIV

Hypertension - NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients

Immunotherapy - Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October

International Aids Vaccine Initiative - IAVI statement in response to NIAID decision not to move forward with PAVE 100 HIV Vaccine Trial

Introgen Therapeutics, Inc. - Introgen to Present ADVEXIN Phase 3 Study Results at American Association for Cancer Research's Cancer Clinical Trials and Personalized Medicine Conference

MacroChem Corporation - MacroChem Announces Phase 2 Data for EcoNail in the Treatment of Onychomycosis

Multiple Myeloma Research Consortium - The Multiple Myeloma Research Consortium MMRC Announces the Initiation of Phase I/II Study of Elotuzumab Huluc63 Monoclonal Antibody in Combination with Velcade

Muscular Dystrophy - Insmed Provides Update on IPLEX(TM) Programs

NicOx - NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement ABPM Studies for Naproxcinod in Hypertensive OA Patients

OncoVista Innovative Therapies, Inc. - OncoVista Innovative Therapies to Begin Enrolling Patients in a Phase I/II Study of Cordycepin in Patients with Refractory TdT-Positive Leukemia

Onychomycosis - MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis

Osteoarthritis - NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension

Perfusion - FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)

Progen Pharmaceuticals Limited - Progen Terminates PATHWAY Trial & Confirms Focus on Potential High Value Molecules and M&A

Provectus Pharmaceuticals, Inc. - Provectus Pharmaceuticals Adds M.D. Anderson as First U.S. Center to Phase 2 Clinical Trial of PV-10

Repros Therapeutics Inc. - Repros Therapeutics Inc. Announces That the Results of the European Trial Demonstrating Uterine Fibroid Size Reduction in Patients Administered Proellex Will Be in Print in August 2008

Seattle Genetics, Inc. - Seattle Genetics Reports Second Quarter 2008 Financial Results

Tranzyme Pharma - Tranzyme Pharma Receives Notices of Allowance from USPTO on Two Patents Protecting Company's Lead Pharmaceutical Development Programs

Urea Cycle Disorders - Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders

Vyteris, Inc. - Vyteris, Inc. Receives $2.5 Million Loan from Ferring Pharmaceuticals, Inc.



Return to Top of Page

-----------------------
PR Login